Development of CRISPR/Cas Genome Editing as a Treatment for Ataxia Telangiectasia - Research - Royal Holloway, University of London

Home > Biological Sciences home > Research > Profile > Projects > Development of CRISPR/Cas Genome Editing as a Treatment for Ataxia Telangiectasia

Development of CRISPR/Cas Genome Editing as a Treatment for Ataxia Telangiectasia

Project: Research

Yáñez-Muñoz, Rafael J. (PI)

Status	Active
Effective start/end date	1/11/17 → 30/04/20

Funding

Action for AT: £200,000

ID: 28655330

Biological Sciences home

Research

Profile

Royal Holloway, University of London
Egham,
Surrey,
TW20 0EX

T: +44 (0)1784 434455 T: +44 (0)1784 434455